Skip to main content
. 2019;20(4):1019–1024. doi: 10.31557/APJCP.2019.20.4.1019

Figure 2.

Figure 2

A, Hazard risk of regression event in association with group age woman (ref. age 25-65 years); B, Hazard risk of progression event in association with cytology diagnostic (ref. cytology diagnostic at AGC)